Latest News
Avalyn Pharma Inc.
- Avalyn Pharma (NASDAQ:AVLN) Stock Falls 5.9% - What's Next?
- Avalyn Pharma (AVLN) Options Chain & Prices 2026
- Avalyn Pharma (NASDAQ:AVLN) Reaches New 52-Week Low - Should You Sell?
- Avalyn Pharma Inc.'s Lock-Up Period Set To End on October 27th (NASDAQ:AVLN)
- Avalyn Pharma (NASDAQ:AVLN) Reaches New 1-Year Low - Should You Sell?
- Avalyn Pharma (NASDAQ:AVLN) Shares Gap Down - Should You Sell?
- Avalyn Pharma (NASDAQ:AVLN) Stock Price Down 5.1% - Here's What Happened
- Avalyn Pharma (NASDAQ:AVLN) Stock Picked Up by Analysts at Raymond James Financial
- Raymond James initiates Avalyn Pharma stock coverage with outperform rating
- Avalyn Pharma Inc. (NASDAQ:AVLN) Stock Now Rated "Moderate Buy" by Wall Street Analysts
- Avalyn Pharma (NASDAQ:AVLN) Stock Jumps 6.4% - Here's What Happened
- Avalyn Pharma publishes Phase 1 data for inhaled AP02 in idiopathic pulmonary fibrosis
Headlines from the last 30 days, linking to the original publishers. See all market news →